 | Up a level |
Wykoff, Charles C; Garweg, Justus G; Regillo, Carl; Souied, Eric; Wolf, Sebastian; Dhoot, Dilsher S; Agostini, Hansjuergen T; Chang, Andrew; Laude, Augustinus; Wachtlin, Joachim; Kovacic, Lidija; Wang, Lixin; Wang, Ying; Bouillaud, Emmanuel; Brown, David M (2024). KESTREL and KITE Phase 3 studies: 100-week results with brolucizumab in patients with diabetic macular edema. American journal of ophthalmology, 260, pp. 70-83. Elsevier Science 10.1016/j.ajo.2023.07.012
